About Ortoma AB

Ortoma AB is a Swedish medical technology company that develops AI-assisted orthopedic surgical software under the Ortoma Treatment Solution (OTS) platform. The company’s primary goal is to improve patient outcomes in orthopedic procedures by providing surgeons with efficient and innovative tools for planning, navigation, and post-operative follow-up of joint implant surgeries. Their systems are designed to optimize the placement of joint implants in hip, knee, and spine surgeries, aiming for better surgical results, fewer complications, and improved long-term implant survival.

For physicians, Ortoma’s OTS platform offers an integrated solution that includes Ortoma Plan and Ortoma Guide. Ortoma Plan is a preoperative planning system that utilizes AI to analyze patient anatomy from CT or MRI scans, create 3D models, and suggest optimal implant choices and positions within seconds. This significantly reduces the time traditionally spent on manual planning, allowing surgeons to focus on strategic decision-making and fine-tuning the surgical approach. Ortoma Guide then provides precise intraoperative navigation, ensuring that implants are positioned according to the meticulously planned strategy. The system also supports post-operative verification and follow-up, using AI to analyze surgical results, detect implant positions, and monitor for migration or wear over time.

Ortoma’s technology is regulatory approved, with OTS Hip Plan and OTS Hip Guide being CE marked and FDA 510(k) approved. They are also expanding their capabilities to convert 2D X-ray images into 3D models, addressing a significant market need where CT scans may not always be available. The company collaborates with leading orthopedic departments and has global partnerships, including with Johnson & Johnson MedTech, for commercialization in various markets.

Focus Areas

AI-assisted orthopedic surgery hip surgery spine surgery surgical planning surgical navigation post-operative follow-up 3D visualization implant positioning

Business Intelligence

Technologycloud-native, AI operating system

What Physicians Need to Know

AI-Assisted Surgical Planning
Ortoma Treatment Solution (OTS) uses AI to automate anatomical landmark identification, bone segmentation, and suggest suitable implants and positions within seconds. This drastically reduces pre-operative planning time, which can take up to 30 minutes with other systems, to just a few minutes for the surgeon to review and approve.
Precision Surgical Navigation
OTS Guide is an intra-operative navigation tool that guides surgeons in real-time to accurately place implants according to the pre-operative plan.
Post-operative Follow-up and Verification
The OTS platform includes a module for post-operative verification and follow-up, using AI to analyze surgical results, automatically detect and verify implant positions. It also allows for comparison of multiple scans over time to monitor implant migration or wear.
3D Visualization and 2D to 3D Conversion
Ortoma's system provides advanced 3D visualization for surgical planning. They have also developed a proof-of-concept solution and prototype for converting 2D X-ray images into 3D models, addressing a significant market need where CT scans might not be available.
Focus on Hip and Spine Surgery
Ortoma's OTS platform is specifically designed for planning and positioning implants in hip and spine surgery, with modules like Hip Plan, Hip Guide, and Spine Plan.
Physician Tip

For physicians, Ortoma's OTS system offers several advantages. The AI-assisted planning significantly reduces the time spent on pre-operative planning, allowing for a more efficient workflow and enabling surgeons to focus on treatment strategy. The precision surgical navigation aims to improve surgical outcomes by guiding accurate implant placement, potentially leading to fewer complications and re-operations, and better long-term implant survival. The post-operative follow-up tools provide valuable data for monitoring implant performance over time. The ability to convert 2D X-rays to 3D models could be particularly beneficial in settings where CT scans are not readily available, streamlining care and potentially reducing costs. The system is designed for easy integration into existing surgical processes.

Ortoma Treatment Solution (OTS) is a server-based AI-integrated orthopedic platform designed for immediate integration into hospital systems. Ortoma has also entered into agreements for the distribution of its OTS Hip solution with companies like Johnson & Johnson K.K. in Japan and DePuy Synthes for worldwide distribution (excluding Japan), indicating potential for broader integration within existing medical technology ecosystems.

Products by Ortoma AB

No products listed for this company yet. Know of one? Suggest it →

What the Web Says

Ortoma AB is a Swedish medical technology company that develops AI-assisted orthopedic surgical software under the Ortoma Treatment Solution (OTS) platform. The company's products, including OTS Hip, aim to improve surgical accuracy, efficiency, and patient outcomes in hip, knee, and spinal surgeries through pre-operative planning, surgical navigation, and post-operative follow-up. The OTS Hip system has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), allowing it to be marketed in the United States. While specific reviews for "Ortoma AB" on G2, Glassdoor, Capterra, and Reddit were not found, general feedback on similar orthopedic software highlights ease of use and efficient patient management.

Overall: Mixed

Strengths

  • AI-assisted technology for improved surgical accuracy, efficiency, and outcomes.
  • Comprehensive platform covering pre-operative planning, surgical navigation, and post-operative follow-up.
  • FDA 510(k) clearance for OTS Hip in the U.S. market and CE-mark for Europe, expanding market potential.
  • Potential for better patient outcomes, fewer complications, and less follow-up surgeries.
  • System can be easily integrated into existing surgical processes and routines.
  • Positive feedback on similar orthopedic software regarding ease of use and efficient patient management.

Limitations

  • No specific product or employer reviews for "Ortoma AB" were found on G2, Glassdoor, Capterra, or Reddit.
  • Some general orthopedic software reviews mention issues with customer support and occasional glitches.
  • One review for a different orthopedic company mentioned poor management and chaotic offices.

Based on reviews from: G2.com, ODTmag.com, Pitchbook.com, Cision.com, Ortoma.com, Investing.com, Indeed.com, Capterra.com

Last updated: 2026-10-31

Videos

News, demos, and interviews about Ortoma AB.

Loading videos...

Videos load interactively. If none appear, search YouTube for Ortoma AB →

View all on YouTube

Press & Coverage

ortoma.com
Ortoma receives FDA 510(k) clearance for OTS™ Hip in the US
Ortoma AB has obtained FDA 510(k) clearance for its OTS™ Hip system, an AI-powered surgical system designed to enhance precision and efficiency in orthopedic procedures, allowing its commercialization in the United States.
2024-03
medworldadvisors.com
Ortoma AB Reaches Agreement with DePuy Synthes for its OTS (Ortoma Treatment Solutions) for Hip Replacement Therapy
Ortoma AB has reached a global development and distribution agreement with DePuy Synthes for its OTS (Ortoma Treatment Solutions) for hip replacement surgery.
2023-09
ortoma.com
Ortoma's OTS™ Hip is launched in Japan
Following a clinical evaluation, Ortoma is collaborating with Johnson & Johnson K.K. to broadly distribute its OTS™ Hip solution in Japan, an AI-assisted orthopedic surgery solution for hip implants.
2023-05
cision.com
Ortoma agrees on term sheet for development and distribution of customized version of OTS Hip
Ortoma AB has agreed on a non-binding term sheet with the DePuy Synthes family of companies for the development and distribution of a customized version of the Ortoma Treatment Solution for hip surgery, OTS Hip.
2022-12
nih.gov
Precision of Cup Positioning Using a Novel Computed Tomography Based Navigation System in Total Hip Arthroplasty
This peer-reviewed article evaluates a novel orthopedic surgical platform, Ortoma Treatment Solution (OTS™), that uses CT imaging with AI-based algorithms to automate aspects of total hip arthroplasty, showing improved surgical precision.
2024-09
odtmag.com
Ortoma Launches AI-Based Software Platform for Implant Surgery
Ortoma AB is launching an artificial intelligence-based software platform, Ortoma Treatment Solution (OTS) 5, designed to improve surgical accuracy for implant procedures, with marketing approval in Europe and the United States.
2021-01
nasdaq.com
Ortoma carries out a 100 per cent guaranteed rights issue of approximately SEK 52 million, and a directed new issue of shares of SEK 16 million
Ortoma AB's Board of Directors has resolved to carry out a rights issue of approximately SEK 52 million and a directed share issue of approximately SEK 16 million to strengthen its financial position and accelerate growth.
2026-03
ortoma.com
Ortoma's rights issue oversubscribed - a total of SEK 68 million will be added to the company
Ortoma AB announced that its fully guaranteed rights issue of approximately SEK 52 million was oversubscribed, and combined with a directed new issue, the company will receive gross proceeds of approximately SEK 68 million.
2026-04

Frequently Asked Questions

Ortoma AB's core product is the Ortoma Treatment Solution (OTS), an AI-assisted digital platform for orthopedic surgery. It is designed for planning and positioning implants in hip, knee, and spinal surgeries, with specific modules like OTS Hip Plan and OTS Hip Guide, and OTS Spine Plan.
Ortoma's OTS platform uses AI to assist surgeons in accurately measuring, planning 3D surgery, and optimally positioning joint implants. The system includes Ortoma Plan for preoperative 3D planning and Ortoma Guide for intraoperative navigation, aiming for better patient outcomes, fewer complications, and improved long-term implant survival rates.
Ortoma AB's OTS Hip system has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), allowing it to be marketed in the United States. The company also holds CE Mark approval for its hip and spine modules in Europe and JP certification for its hip implant planning module in Japan.
Ortoma AB has established significant strategic partnerships, notably with Johnson & Johnson K.K. for exclusive distribution rights of OTS Hip in Japan. They also have a development and distribution agreement with DePuy Synthes, part of Johnson & Johnson MedTech, for a customized OTS solution for hip replacement surgery, aiming for global market establishment.
The Ortoma Treatment Solution is designed for easy integration into existing surgical processes and routines, enhancing efficiency without significant workflow deviation. As a digital, server-based AI platform, it processes medical imaging data in DICOM format for preoperative planning and intraoperative guidance.
Ortoma AB is a publicly traded company listed on the Spotlight Stock Market in Sweden and Nasdaq Stockholm. While the company has reported revenue, it has also shown net losses in recent fiscal years, and its employee count is typically between 15 and 50.
Ortoma has developed and presented a proof-of-concept solution for converting 2D X-ray images into 3D models. This innovative technology aims to further enhance preoperative planning capabilities within their Ortoma Treatment Solution platform.

Related Companies

OrthoAI is a healthcare AI company that has two distinct entities. One OrthoAI, based in India, is an AI-powered surgical companion designed for orthopedic surgeons, providing evidence-based insights and decision support. It functions as a generative AI, similar to ChatGPT, specifically tailored for orthopedics, and is accessible 24/7. This platform integrates a curated database developed […]

NuvoAir is a digital health company that provides a value-based specialty care platform focused on proactive, continuous virtual care for individuals with heart and lung conditions. The company aims to transform the diagnosis and management of chronic cardiopulmonary conditions by integrating advanced monitoring technology, data analytics, and evidence-based interventions delivered by a multidisciplinary team. NuvoAir’s […]

Infinite Biomedical Technologies, LLC (IBT) is a medical device company established in 1997 with roots at Johns Hopkins University. The company is dedicated to developing innovative solutions for individuals with upper limb loss and differences, aiming to transform laboratory research into practical medical devices. IBT focuses on advanced prosthetic control systems and related technologies to […]

The search results indicate that “Strain AI” is not a single, unified company serving physicians and healthcare providers in the traditional medical sense. Instead, the term “Strain AI” appears to be a general descriptor used by several distinct companies operating primarily in the cannabis industry, leveraging AI to recommend cannabis strains based on user preferences, […]

Samsung is a global technology leader that has significantly expanded its presence in the healthcare sector, leveraging its expertise in AI, imaging, and connected devices. The company aims to improve patient care and outcomes by providing advanced diagnostic solutions, personalized health insights, and integrated digital health platforms. Samsung’s healthcare initiatives focus on bridging the gap […]

Philips (Cardiologs) is a healthcare AI company that specializes in transforming cardiac diagnostics through medical-grade artificial intelligence and cloud technology. Their core offering is the Cardiologs Holter platform, which utilizes deep neural networks to analyze continuous ambulatory ECGs. This platform is designed to streamline ECG analysis, reduce reporting errors, and accelerate diagnostic reporting, ultimately empowering […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.